COVID-19 Impact on Global Targeted Drug HER2 Inhibitors for NSCLC Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-targeted-drug-her2-inhibitors-4-nsclc-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Targeted Drug HER2 Inhibitors for NSCLC status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Targeted Drug HER2 Inhibitors for NSCLC development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Boehringer-Ingelheim
- Roche
- Mylan
- Biocon
- Afatinib
- Trastuzumab
- Other
- Squamous Cell Carcinoma of NSCLC
- Adenocarcinoma of NSCLC
- Large Cell Carcinoma of NSCLC
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global Targeted Drug HER2 Inhibitors for NSCLC status, future forecast, growth opportunity, key market and key players.
- To present the Targeted Drug HER2 Inhibitors for NSCLC development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Targeted Drug HER2 Inhibitors for NSCLC Revenue
1.4 Market Analysis by Type
1.4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Afatinib
1.4.3 Trastuzumab
1.4.4 Other
1.5 Market by Application
1.5.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application: 2020 VS 2026
1.5.2 Squamous Cell Carcinoma of NSCLC
1.5.3 Adenocarcinoma of NSCLC
1.5.4 Large Cell Carcinoma of NSCLC
1.6 Coronavirus Disease 2019 (Covid-19): Targeted Drug HER2 Inhibitors for NSCLC Industry Impact
1.6.1 How the Covid-19 is Affecting the Targeted Drug HER2 Inhibitors for NSCLC Industry
1.6.1.1 Targeted Drug HER2 Inhibitors for NSCLC Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Targeted Drug HER2 Inhibitors for NSCLC Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Targeted Drug HER2 Inhibitors for NSCLC Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Targeted Drug HER2 Inhibitors for NSCLC Market Perspective (2015-2026)
2.2 Targeted Drug HER2 Inhibitors for NSCLC Growth Trends by Regions
2.2.1 Targeted Drug HER2 Inhibitors for NSCLC Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Targeted Drug HER2 Inhibitors for NSCLC Historic Market Share by Regions (2015-2020)
2.2.3 Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Targeted Drug HER2 Inhibitors for NSCLC Market Growth Strategy
2.3.6 Primary Interviews with Key Targeted Drug HER2 Inhibitors for NSCLC Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Market Size
3.1.1 Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Revenue (2015-2020)
3.1.2 Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Players (2015-2020)
3.1.3 Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio
3.2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2019
3.3 Targeted Drug HER2 Inhibitors for NSCLC Key Players Head office and Area Served
3.4 Key Players Targeted Drug HER2 Inhibitors for NSCLC Product Solution and Service
3.5 Date of Enter into Targeted Drug HER2 Inhibitors for NSCLC Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Type (2015-2020)
4.2 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2021-2026)
5 TARGETED DRUG HER2 INHIBITORS FOR NSCLC BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
5.2 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
6.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in North America (2019-2020)
6.3 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
6.4 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
7.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in Europe (2019-2020)
7.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
7.4 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
8 CHINA
8.1 China Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
8.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in China (2019-2020)
8.3 China Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
8.4 China Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
9.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in Japan (2019-2020)
9.3 Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
9.4 Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
10.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
10.4 Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
11 INDIA
11.1 India Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
11.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in India (2019-2020)
11.3 India Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
11.4 India Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
12.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in Central & South America (2019-2020)
12.3 Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
12.4 Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Boehringer-Ingelheim
13.1.1 Boehringer-Ingelheim Company Details
13.1.2 Boehringer-Ingelheim Business Overview and Its Total Revenue
13.1.3 Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Introduction
13.1.4 Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020))
13.1.5 Boehringer-Ingelheim Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview and Its Total Revenue
13.2.3 Roche Targeted Drug HER2 Inhibitors for NSCLC Introduction
13.2.4 Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview and Its Total Revenue
13.3.3 Mylan Targeted Drug HER2 Inhibitors for NSCLC Introduction
13.3.4 Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 Biocon
13.4.1 Biocon Company Details
13.4.2 Biocon Business Overview and Its Total Revenue
13.4.3 Biocon Targeted Drug HER2 Inhibitors for NSCLC Introduction
13.4.4 Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
13.4.5 Biocon Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Targeted Drug HER2 Inhibitors for NSCLC Revenue
1.4 Market Analysis by Type
1.4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Afatinib
1.4.3 Trastuzumab
1.4.4 Other
1.5 Market by Application
1.5.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application: 2020 VS 2026
1.5.2 Squamous Cell Carcinoma of NSCLC
1.5.3 Adenocarcinoma of NSCLC
1.5.4 Large Cell Carcinoma of NSCLC
1.6 Coronavirus Disease 2019 (Covid-19): Targeted Drug HER2 Inhibitors for NSCLC Industry Impact
1.6.1 How the Covid-19 is Affecting the Targeted Drug HER2 Inhibitors for NSCLC Industry
1.6.1.1 Targeted Drug HER2 Inhibitors for NSCLC Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Targeted Drug HER2 Inhibitors for NSCLC Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Targeted Drug HER2 Inhibitors for NSCLC Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Targeted Drug HER2 Inhibitors for NSCLC Market Perspective (2015-2026)
2.2 Targeted Drug HER2 Inhibitors for NSCLC Growth Trends by Regions
2.2.1 Targeted Drug HER2 Inhibitors for NSCLC Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Targeted Drug HER2 Inhibitors for NSCLC Historic Market Share by Regions (2015-2020)
2.2.3 Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Targeted Drug HER2 Inhibitors for NSCLC Market Growth Strategy
2.3.6 Primary Interviews with Key Targeted Drug HER2 Inhibitors for NSCLC Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Market Size
3.1.1 Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Revenue (2015-2020)
3.1.2 Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Players (2015-2020)
3.1.3 Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio
3.2.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2019
3.3 Targeted Drug HER2 Inhibitors for NSCLC Key Players Head office and Area Served
3.4 Key Players Targeted Drug HER2 Inhibitors for NSCLC Product Solution and Service
3.5 Date of Enter into Targeted Drug HER2 Inhibitors for NSCLC Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Targeted Drug HER2 Inhibitors for NSCLC Historic Market Size by Type (2015-2020)
4.2 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Type (2021-2026)
5 TARGETED DRUG HER2 INHIBITORS FOR NSCLC BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
5.2 Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
6.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in North America (2019-2020)
6.3 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
6.4 North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
7.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in Europe (2019-2020)
7.3 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
7.4 Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
8 CHINA
8.1 China Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
8.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in China (2019-2020)
8.3 China Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
8.4 China Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
9.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in Japan (2019-2020)
9.3 Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
9.4 Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
10.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
10.4 Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
11 INDIA
11.1 India Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
11.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in India (2019-2020)
11.3 India Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
11.4 India Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size (2015-2020)
12.2 Targeted Drug HER2 Inhibitors for NSCLC Key Players in Central & South America (2019-2020)
12.3 Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020)
12.4 Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Boehringer-Ingelheim
13.1.1 Boehringer-Ingelheim Company Details
13.1.2 Boehringer-Ingelheim Business Overview and Its Total Revenue
13.1.3 Boehringer-Ingelheim Targeted Drug HER2 Inhibitors for NSCLC Introduction
13.1.4 Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020))
13.1.5 Boehringer-Ingelheim Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview and Its Total Revenue
13.2.3 Roche Targeted Drug HER2 Inhibitors for NSCLC Introduction
13.2.4 Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview and Its Total Revenue
13.3.3 Mylan Targeted Drug HER2 Inhibitors for NSCLC Introduction
13.3.4 Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 Biocon
13.4.1 Biocon Company Details
13.4.2 Biocon Business Overview and Its Total Revenue
13.4.3 Biocon Targeted Drug HER2 Inhibitors for NSCLC Introduction
13.4.4 Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
13.4.5 Biocon Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Targeted Drug HER2 Inhibitors for NSCLC Key Market Segments
Table 2. Key Players Covered: Ranking by Targeted Drug HER2 Inhibitors for NSCLC Revenue
Table 3. Ranking of Global Top Targeted Drug HER2 Inhibitors for NSCLC Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Afatinib
Table 6. Key Players of Trastuzumab
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Targeted Drug HER2 Inhibitors for NSCLC Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Targeted Drug HER2 Inhibitors for NSCLC Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Targeted Drug HER2 Inhibitors for NSCLC Players to Combat Covid-19 Impact
Table 13. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions (2015-2020)
Table 17. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Targeted Drug HER2 Inhibitors for NSCLC Market Growth Strategy
Table 23. Main Points Interviewed from Key Targeted Drug HER2 Inhibitors for NSCLC Players
Table 24. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue by Players (2015-2020) (Million US$)
Table 25. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players (2015-2020)
Table 26. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2019)
Table 27. Global Targeted Drug HER2 Inhibitors for NSCLC by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Targeted Drug HER2 Inhibitors for NSCLC Product Solution and Service
Table 30. Date of Enter into Targeted Drug HER2 Inhibitors for NSCLC Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 33. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Type (2015-2020)
Table 34. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2021-2026)
Table 35. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Application (2015-2020)
Table 36. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 37. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Application (2021-2026)
Table 38. North America Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 40. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 41. North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 42. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 43. North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 44. Europe Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 46. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 48. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 50. China Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 51. China Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 52. China Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 53. China Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 54. China Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 55. China Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 56. Japan Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 58. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 60. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 64. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 66. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 68. India Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 69. India Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 70. India Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 71. India Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 72. India Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 73. India Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 76. Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 78. Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 80. Boehringer-Ingelheim Company Details
Table 81. Boehringer-Ingelheim Business Overview
Table 82. Boehringer-Ingelheim Product
Table 83. Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 84. Boehringer-Ingelheim Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Product
Table 88. Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 89. Roche Recent Development
Table 90. Mylan Company Details
Table 91. Mylan Business Overview
Table 92. Mylan Product
Table 93. Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 94. Mylan Recent Development
Table 95. Biocon Company Details
Table 96. Biocon Business Overview
Table 97. Biocon Product
Table 98. Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 99. Biocon Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 1. Targeted Drug HER2 Inhibitors for NSCLC Key Market Segments
Table 2. Key Players Covered: Ranking by Targeted Drug HER2 Inhibitors for NSCLC Revenue
Table 3. Ranking of Global Top Targeted Drug HER2 Inhibitors for NSCLC Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Afatinib
Table 6. Key Players of Trastuzumab
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Targeted Drug HER2 Inhibitors for NSCLC Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Targeted Drug HER2 Inhibitors for NSCLC Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Targeted Drug HER2 Inhibitors for NSCLC Players to Combat Covid-19 Impact
Table 13. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions (2015-2020)
Table 17. Global Targeted Drug HER2 Inhibitors for NSCLC Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Targeted Drug HER2 Inhibitors for NSCLC Market Growth Strategy
Table 23. Main Points Interviewed from Key Targeted Drug HER2 Inhibitors for NSCLC Players
Table 24. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue by Players (2015-2020) (Million US$)
Table 25. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players (2015-2020)
Table 26. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2019)
Table 27. Global Targeted Drug HER2 Inhibitors for NSCLC by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Targeted Drug HER2 Inhibitors for NSCLC Product Solution and Service
Table 30. Date of Enter into Targeted Drug HER2 Inhibitors for NSCLC Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 33. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Type (2015-2020)
Table 34. Global Targeted Drug HER2 Inhibitors for NSCLC Revenue Market Share by Type (2021-2026)
Table 35. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Application (2015-2020)
Table 36. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 37. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size Share by Application (2021-2026)
Table 38. North America Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 40. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 41. North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 42. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 43. North America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 44. Europe Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 46. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 48. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 50. China Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 51. China Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 52. China Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 53. China Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 54. China Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 55. China Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 56. Japan Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 58. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 60. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 64. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 66. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 68. India Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 69. India Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 70. India Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 71. India Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 72. India Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 73. India Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Targeted Drug HER2 Inhibitors for NSCLC Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Targeted Drug HER2 Inhibitors for NSCLC Market Share (2019-2020)
Table 76. Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type (2015-2020)
Table 78. Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application (2015-2020)
Table 80. Boehringer-Ingelheim Company Details
Table 81. Boehringer-Ingelheim Business Overview
Table 82. Boehringer-Ingelheim Product
Table 83. Boehringer-Ingelheim Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 84. Boehringer-Ingelheim Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Product
Table 88. Roche Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 89. Roche Recent Development
Table 90. Mylan Company Details
Table 91. Mylan Business Overview
Table 92. Mylan Product
Table 93. Mylan Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 94. Mylan Recent Development
Table 95. Biocon Company Details
Table 96. Biocon Business Overview
Table 97. Biocon Product
Table 98. Biocon Revenue in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020) (Million US$)
Table 99. Biocon Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type: 2020 VS 2026
Figure 2. Afatinib Features
Figure 3. Trastuzumab Features
Figure 4. Other Features
Figure 5. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application: 2020 VS 2026
Figure 6. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 7. Adenocarcinoma of NSCLC Case Studies
Figure 8. Large Cell Carcinoma of NSCLC Case Studies
Figure 9. Targeted Drug HER2 Inhibitors for NSCLC Report Years Considered
Figure 10. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions: 2020 VS 2026
Figure 12. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players in 2019
Figure 15. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2019
Figure 17. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Boehringer-Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Boehringer-Ingelheim Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
Figure 26. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Roche Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
Figure 28. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Mylan Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
Figure 30. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Biocon Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
Figure 32. Bottom-up and Top-down Approaches for This Report
Figure 33. Data Triangulation
Figure 34. Key Executives Interviewed
Figure 1. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Type: 2020 VS 2026
Figure 2. Afatinib Features
Figure 3. Trastuzumab Features
Figure 4. Other Features
Figure 5. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Application: 2020 VS 2026
Figure 6. Squamous Cell Carcinoma of NSCLC Case Studies
Figure 7. Adenocarcinoma of NSCLC Case Studies
Figure 8. Large Cell Carcinoma of NSCLC Case Studies
Figure 9. Targeted Drug HER2 Inhibitors for NSCLC Report Years Considered
Figure 10. Global Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions: 2020 VS 2026
Figure 12. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Targeted Drug HER2 Inhibitors for NSCLC Market Share by Players in 2019
Figure 15. Global Top Targeted Drug HER2 Inhibitors for NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Targeted Drug HER2 Inhibitors for NSCLC as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Targeted Drug HER2 Inhibitors for NSCLC Revenue in 2019
Figure 17. North America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Targeted Drug HER2 Inhibitors for NSCLC Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Boehringer-Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Boehringer-Ingelheim Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
Figure 26. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Roche Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
Figure 28. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Mylan Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
Figure 30. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Biocon Revenue Growth Rate in Targeted Drug HER2 Inhibitors for NSCLC Business (2015-2020)
Figure 32. Bottom-up and Top-down Approaches for This Report
Figure 33. Data Triangulation
Figure 34. Key Executives Interviewed